| pubmed-article:842883 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:842883 | lifeskim:mentions | umls-concept:C0042960 | lld:lifeskim |
| pubmed-article:842883 | lifeskim:mentions | umls-concept:C1549078 | lld:lifeskim |
| pubmed-article:842883 | lifeskim:mentions | umls-concept:C0002903 | lld:lifeskim |
| pubmed-article:842883 | lifeskim:mentions | umls-concept:C1997894 | lld:lifeskim |
| pubmed-article:842883 | lifeskim:mentions | umls-concept:C0014277 | lld:lifeskim |
| pubmed-article:842883 | lifeskim:mentions | umls-concept:C0016327 | lld:lifeskim |
| pubmed-article:842883 | lifeskim:mentions | umls-concept:C0018549 | lld:lifeskim |
| pubmed-article:842883 | lifeskim:mentions | umls-concept:C1881215 | lld:lifeskim |
| pubmed-article:842883 | lifeskim:mentions | umls-concept:C0439590 | lld:lifeskim |
| pubmed-article:842883 | lifeskim:mentions | umls-concept:C0599918 | lld:lifeskim |
| pubmed-article:842883 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:842883 | pubmed:dateCreated | 1977-4-30 | lld:pubmed |
| pubmed-article:842883 | pubmed:abstractText | The effects of prolonged enflurane and halothane administration on urine-concentrating ability were determined in volunteers by examining their responses to vasopressin before anesthesia and on days 1 and 5 after anesthesia. A significant decrease in maximum urinary osmolality of 264 +/- 34 mOsm/kg (26 per cent of the preanesthetic value) was present on day 1 after enflurane anesthesia, whereas subjects anesthetized with halothane had a significant increase in maximum urinary osmolality of 120 +/- 44 mOsm/kg. Serum inorganic fluoride level peaked at 33.6 muM and remained above 20 muM for approximately 18 hours. Thus, the threshold level for inorganic fluoride nephrotoxicity is lower than previously suspected. | lld:pubmed |
| pubmed-article:842883 | pubmed:language | eng | lld:pubmed |
| pubmed-article:842883 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:842883 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:842883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:842883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:842883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:842883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:842883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:842883 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:842883 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:842883 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:842883 | pubmed:issn | 0003-3022 | lld:pubmed |
| pubmed-article:842883 | pubmed:author | pubmed-author:MazzeR IRI | lld:pubmed |
| pubmed-article:842883 | pubmed:author | pubmed-author:SmithN TNT | lld:pubmed |
| pubmed-article:842883 | pubmed:author | pubmed-author:CalverleyR... | lld:pubmed |
| pubmed-article:842883 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:842883 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:842883 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:842883 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:842883 | pubmed:pagination | 265-71 | lld:pubmed |
| pubmed-article:842883 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-H... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-F... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-V... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-B... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-M... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-A... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-M... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-H... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-G... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-O... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-K... | lld:pubmed |
| pubmed-article:842883 | pubmed:meshHeading | pubmed-meshheading:842883-E... | lld:pubmed |
| pubmed-article:842883 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:842883 | pubmed:articleTitle | Inorganic fluoride nephrotoxicity: prolonged enflurane and halothane anesthesia in volunteers. | lld:pubmed |
| pubmed-article:842883 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:842883 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:842883 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:842883 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:842883 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:842883 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:842883 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:842883 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:842883 | lld:pubmed |
